177Lu-DOTATATE Shows Promising Efficacy in the Treatment of Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas By Ogkologos - September 2, 2025 269 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the Phase II study Source RELATED ARTICLESMORE FROM AUTHOR Multicancer early detection test detects tumour-derived cfDNA and demonstrates robust performance characteristics with a favourable safety profile Anito-cel, a d-Domain BCMA CAR T-Cell, Induces Rapid, Deep, and Durable Responses in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma EMA Recommends Granting a Marketing Authorisation for Relacorilant MOST POPULAR Breast Cancer Surgery Choice May Affect Young Survivors’ Quality of Life September 30, 2021 No Clinical Benefit from Nivolumab Plus Ipilimumab Over Nivolumab Alone as... April 14, 2023 New study supports extending cervical screening intervals for people who test... May 31, 2022 FDA Approves Amivantamab and Hyaluronidase-lpuj for Subcutaneous Injection January 14, 2026 Load more HOT NEWS Remodeled CAR T-Cell Therapy Reduces Side Effects in First Clinical Trial New study identifies how obesity may increase the risk of developing... Woman Donates 500 Care Packages To Breast Cancer Patients Police Officer Has Bulletproof Vest to Thank for Helping Her Discover...
